Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amarin Announces 30th Patent for Vascepa(R)
Yahoo
Monday, September 9, 2013 - 10:41am
tags:
Amarin, Vascepa, patents
Pharma Blasts EMA Draft Policy On Disclosing Clinical Trial Data
Pharmalot
Monday, September 9, 2013 - 10:40am
tags:
clinical trial data, clinical trials, EMA
Baxter and Gambro seal the deal on $3.9B acquisition
Mass Device
Monday, September 9, 2013 - 10:39am
tags:
Baxter International, Gambro, M&A, devices
Bayer's Xarelto faces stepped-up reports of side effects, deaths
Fierce Pharma
Monday, September 9, 2013 - 10:26am
tags:
Bayer, Xarelto, bloodthinners
Boehringer targets sales reps in new round of French job cuts
Fierce Pharma
Monday, September 9, 2013 - 10:25am
tags:
Boehringer Ingelheim, layoffs, France
Vivus' Qsymia Scripts Remain Flat
Seeking Alpha
Monday, September 9, 2013 - 9:55am
tags:
obesity, Arena Pharmaceuticals, Belviq, Eisai, Vivus, Qsymia, Anthony Zook
Assessing Arena's Belviq Sales After 3 Months
Seeking Alpha
Monday, September 9, 2013 - 9:54am
tags:
obesity, Arena Pharmaceuticals, Belviq, Eisai, Vivus, Qsymia
PDL BioPharma says 3Q revenue climbed 14 percent
Yahoo/AP
Monday, September 9, 2013 - 9:53am
tags:
earnings, PDL Biopharma
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Yahoo
Monday, September 9, 2013 - 9:52am
tags:
Biodel, BIOD-123, clinical trials, diabetes, type 1 diabetes
Gentium: Several Underappreciated Investment Positives
Seeking Alpha
Monday, September 9, 2013 - 9:51am
tags:
Gentium, Defibrotide
Biogen Expands Isis Partnership in $100 Million Drug Deal
Bloomberg
Monday, September 9, 2013 - 9:46am
tags:
Biogen Idec, Isis Pharmaceuticals, R&D
Pfizer cancer drug Sutent linked to severe skin reactions
CBC News
Monday, September 9, 2013 - 9:44am
tags:
Pfizer, Sutent, cancer, Stevens Johnson Syndrome
DiaDexus: A Hearty Choice
Seeking Alpha
Monday, September 9, 2013 - 9:42am
tags:
diaDexus, coronary artery disease, GSK, PLAC ELISA Test, diagnostics, devices
Merck Announces FDA Acceptance of New Drug Application for Investigational Fertility Treatment
Yahoo
Monday, September 9, 2013 - 9:24am
tags:
Merck, FDA, Fertility, corifollitropin alfa
Glaxo to Sell Drink Brands for $2.1 Billion
NY Times, NY
Monday, September 9, 2013 - 9:21am
tags:
M&A, GSK, Japan
Why GlaxoSmithKline Plc Has Gained 23% Since This Time Last Year
Motley Fool
Monday, September 9, 2013 - 9:12am
tags:
GSK
Hey, Celsion - Tell Me Something Good
Seeking Alpha
Sunday, September 8, 2013 - 11:17am
tags:
Celsion
Agenus Offers An Investment Opportunity
Seeking Alpha
Sunday, September 8, 2013 - 11:16am
tags:
Agenus
Lawsuit Alleges Takeda Pharmaceutical Co., Maker Of Diabetes Drug Actos, Didn’t Warn Of The Drug’s Risks Soon Enough; Parker Waichman LLP Responds
Daily Markets
Sunday, September 8, 2013 - 11:14am
tags:
Takeda, lawsuits, diabetes, Actos
Rockwell Medical Inc: SFP's Market Potential
Seeking Alpha
Sunday, September 8, 2013 - 11:12am
tags:
Rockwell Medical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.